WS
ZOM

Wedbush Securities’s Zomedica Corp. ZOM Stock Holding History

Wedbush Securities’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,500
Closed -$1K – 1215
2025
Q1 		$1K Hold
11,500
– – ﹤0.01% 1111
2024
Q4 		$1K Buy
+11,500
New +$1.45K ﹤0.01% 1136

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
RF
Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

Wedbush Securities's ZOM Position: Q2 2025 in Review

Wedbush Securities sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 11,500 shares — an estimated $1K sold.

Wedbush Securities first reported a position in ZOM in Q4 2024 and held it in 2 quarters. The position peaked at $1K in Q1 2025. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Wedbush Securities reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Wedbush Securities sold 11,500 Zomedica Corp. shares in Q2 2025, an estimated $1K.
  • Wedbush Securities first reported a position in Zomedica Corp. in Q4 2024 and held it in 2 quarters.
  • Wedbush Securities's Zomedica Corp. position peaked at $1K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Wedbush Securities's 13F filing for Q2 2025, filed 6 Aug 2025.